These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 14738585

  • 1. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori.
    Umamaheshwari RB, Jain S, Bhadra D, Jain NK.
    J Pharm Pharmacol; 2003 Dec; 55(12):1607-13. PubMed ID: 14738585
    [Abstract] [Full Text] [Related]

  • 2. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.
    Ohta T, Shibata H, Kawamori T, Iimuro M, Sugimura T, Wakabayashi K.
    Biochem Biophys Res Commun; 2001 Jul 20; 285(3):728-33. PubMed ID: 11453654
    [Abstract] [Full Text] [Related]

  • 3. Floating in situ gelling system of acetohydroxamic acid for clearance of H. pylori.
    Rajinikanth PS, Mishra B.
    Drug Dev Ind Pharm; 2008 Jun 20; 34(6):577-87. PubMed ID: 18568907
    [Abstract] [Full Text] [Related]

  • 4. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK, Chavda JR.
    J Microencapsul; 2009 Jun 20; 26(4):365-76. PubMed ID: 18720199
    [Abstract] [Full Text] [Related]

  • 5. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori.
    Jain SK, Jangdey MS.
    Mol Pharm; 2009 Jun 20; 6(1):295-304. PubMed ID: 19093870
    [Abstract] [Full Text] [Related]

  • 6. Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori.
    Umamaheswari RB, Jain S, Tripathi PK, Agrawal GP, Jain NK.
    Drug Deliv; 2002 Jun 20; 9(4):223-31. PubMed ID: 12511200
    [Abstract] [Full Text] [Related]

  • 7. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy.
    Ishak RA, Awad GA, Mortada ND, Nour SA.
    J Control Release; 2007 Jun 04; 119(2):207-14. PubMed ID: 17412443
    [Abstract] [Full Text] [Related]

  • 8. Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori.
    Umamaheshwari RB, Jain NK.
    J Control Release; 2004 Sep 14; 99(1):27-40. PubMed ID: 15342178
    [Abstract] [Full Text] [Related]

  • 9. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.
    Umamaheshwari RB, Ramteke S, Jain NK.
    AAPS PharmSciTech; 2004 Apr 07; 5(2):e32. PubMed ID: 15760090
    [Abstract] [Full Text] [Related]

  • 10. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA, Gide PS.
    Drug Deliv; 2016 Apr 07; 23(2):405-19. PubMed ID: 24870198
    [Abstract] [Full Text] [Related]

  • 11. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.
    Rajinikanth PS, Karunagaran LN, Balasubramaniam J, Mishra B.
    Chem Pharm Bull (Tokyo); 2008 Dec 07; 56(12):1658-64. PubMed ID: 19043235
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of floating drug delivery system of azithromycin.
    Wasnik S, Parmar P, Singh D, Ram A.
    Acta Pol Pharm; 2012 Dec 07; 69(3):515-22. PubMed ID: 22594266
    [Abstract] [Full Text] [Related]

  • 13. Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori.
    Rajinikanth PS, Mishra B.
    Acta Pharm; 2007 Dec 07; 57(4):413-27. PubMed ID: 18165186
    [Abstract] [Full Text] [Related]

  • 14. Effects of indomethacin and rofecoxib on gastric mucosal damage in normal and Helicobacter pylori-infected mongolian gerbils.
    Kanatani K, Ebata M, Murakami M, Okabe S.
    J Physiol Pharmacol; 2004 Mar 07; 55(1 Pt 2):207-22. PubMed ID: 15082879
    [Abstract] [Full Text] [Related]

  • 15. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori.
    Rajinikanth PS, Mishra B.
    J Control Release; 2008 Jan 04; 125(1):33-41. PubMed ID: 18006101
    [Abstract] [Full Text] [Related]

  • 16. Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: a Novel Approach for Effective Treatment of H. pylori.
    Jain SK, Haider T, Kumar A, Jain A.
    AAPS PharmSciTech; 2016 Oct 04; 17(5):1131-40. PubMed ID: 26566630
    [Abstract] [Full Text] [Related]

  • 17. Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori.
    Patel SS, Ray S, Thakur RS.
    Acta Pol Pharm; 2006 Oct 04; 63(1):53-61. PubMed ID: 17515330
    [Abstract] [Full Text] [Related]

  • 18. Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils.
    Hejazi R, Amiji M.
    Int J Pharm; 2004 Mar 19; 272(1-2):99-108. PubMed ID: 15019073
    [Abstract] [Full Text] [Related]

  • 19. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
    Rajinikanth PS, Balasubramaniam J, Mishra B.
    Int J Pharm; 2007 Apr 20; 335(1-2):114-122. PubMed ID: 17141986
    [Abstract] [Full Text] [Related]

  • 20. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.
    Jain SK, Awasthi AM, Jain NK, Agrawal GP.
    J Control Release; 2005 Oct 03; 107(2):300-9. PubMed ID: 16095748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.